Cic edizioni internazionali
Functional Neurology

Recent advances in the molecular genetics of frontotemporal lobar degeneration

Review article, 7 - 16
doi: 10.11138/FNeur/2017.32.1.007
Tag this article
Abstract
Enhanced HTML Full text PDF
The term frontotemporal lobar degeneration (FTLD) describes a spectrum of neurodegenerative disorders associated with deposition of misfolded proteins in the frontal and temporal lobes. Up to 40% of FTLD patients reports a family history of neurodegeneration, and approximately 1/3 of familial cases shows an autosomal dominant pattern of inheritance of the phenotype. Over the past two decades, several causative and susceptibility genes for FTLD have been discovered, supporting the notion that genetic factors are important contributors to the disease processes. Genetic variants in three genes, MAPT, GRN and C9orf72, account for about half of familial FTLD cases. In addition, rare defects in the CHMP2B, VCP, TARDBP, SQSTM1, FUS, UBQLN, OPTN, TREM2, CHCHD10 and TBK1 genes have been described. Additional genes are expected to be found in near future.
The purpose of this review is to describe recent advances in the molecular genetics of the FTLD spectrum and to discuss implications for genetic counseling.

Vol. XXXIII (No. 3) 2018 July/September

  1. Errata corrige Functional Neurology 2018;33:2 Article: Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
  2. Chronic stroke: an oxymoron or a challenge for rehabilitation?
    Baricich A., Carda S.
    doi: 10.11138/FNeur/2018.33.3.123
  3. Effects of a nutraceutical combination in patients with chronic lumbosacral radicular pain
    Geroin C., Tamburin S., Pagano G., Gandolfi M., Tinazzi M.
    doi: 10.11138/FNeur/2018.33.3.125
  4. Effects on balance skills and patient compliance of biofeedback training with inertial measurement units and exergaming in subacute stroke: a pilot randomized controlled trial
    Lupo A., Cinnera A.M., Pucello A., Iosa M., Coiro P., Personeni S., Gimigliano F., Iolascon G., Paolucci S., Morone G.
    doi: 10.11138/FNeur/2018.33.3.131
  5. The required coefficient of friction in Parkinson’s disease: people with freezing of gait
    Rozin Kleiner A.F., Cubillos D.M., Pinto C., Salazar A.P., Marchese R.R., Barros R.M.L., Galli M., Pagnussat A.S.
    doi: 10.11138/FNeur/2018.33.3.137
  6. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial
    Dimitriou T.-D., Verykouki E., Papatriantafyllou J., Konsta A., Kazis D., Tsolaki M.
    doi: 10.11138/FNeur/2018.33.3.143
  7. Improved antioxidant defense in the ventral tegmental area increases pain tolerance in male rats
    Famitafreshi H., Karimian M.
    doi: 10.11138/FNeur/2018.33.3.149
  8. Neurite orientation dispersion and density imaging can detect presymptomatic axonal degeneration in the spinal cord of ALS mice
    Gatto R.G., Mustafi S.M., Amin M.Y., Mareci T.H., Wu Y.-C., Magin R.L.
    doi: 10.11138/FNeur/2018.33.3.155
  9. An acute neurological complication of Crohn’s disease
    Battista F., Tinella E., Colosimo C.
    doi: 10.11138/FNeur/2018.33.3.165
  10. Shaping a pain-free future for cluster headache patients. The Declaration of Paris
    Rossi P., Bruce S., De Pascual M.A., Muller H., Tyminski E.K., De La Torre E.R.
    doi: 10.11138/FNeur/2018.33.3.167
Last Viewed articles: la lista degli ultimi x visitati.
  1. Recent advances in the molecular genetics of frontotemporal lobar degeneration
    Rainero I., Rubino E., Michelerio A., D'Agata F., Gentile S., Pinessi L.
    doi: 10.11138/FNeur/2017.32.1.007
credits